Brief: Astrazeneca Pharma India June-Quarter PAT Falls
09/08/2021 09:45
Aug 9 (Reuters) - Astrazeneca Pharma India Ltd ASTR.NS :
* JUNE-QUARTER PAT 102.4 MILLION RUPEES VERSUS PROFIT 186.3
MILLION RUPEES YEAR AGO
* JUNE-QUARTER REVENUE FROM OPERATIONS 1.75 BILLION RUPEES
VERSUS
1.94 BILLION RUPEES YEAR AGO
* DECLARED INTERIM DIVIDEND OF 2 RUPEES/SHARE
Further company coverage: ASTR.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Astrazeneca Pharma India
See all newsBrief: Astrazeneca Pharma India Receives Permission To Import And Sell Trastuzumab Deruxtecan For Additional Indication
Brief: Astrazeneca Pharma Says Bhavana Agrawal Resigns As CFO
Brief: Astrazeneca Pharma India Receives Permission To Import And Sell Benralizumab For Additional Indication
Brief: Astrazeneca Pharma India Receives Permission To Import Benralizumab (Fasenra) For Additional Indication
Brief: Astrazeneca Pharma Gets Permission To Import For Sale Of Trastuzumab Deruxtecan